PRGS Progress Software Corporation

Progress Sets the Standard for Application Development with Generative AI Integration, Enhanced Design System Capabilities and Accessible Data Visualization

Progress Sets the Standard for Application Development with Generative AI Integration, Enhanced Design System Capabilities and Accessible Data Visualization

Latest Q2 2024 release enables developers to integrate Generative AI into any app and to rapidly build and design innovative, inclusive digital experiences

BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced the latest release of and , the most powerful .NET and JavaScript UI libraries and tools for application development. Today’s release delivers artificial intelligence (AI) prompts to application interfaces, design-to-code productivity, accessibility features and a series of new UI components, including the first-to-market Blazor Spreadsheet component.

“Businesses are rapidly adapting their products to take advantage of AI, and developers have to respond quickly to this new opportunity,” said Loren Jarrett, EVP & GM, Digital Experience, Progress. “With this latest release, we make it easy for developers to include Gen AI prompts in their apps and embed AI for a better UX in addition to advanced design-to-code automation and accessibility features. The world is moving quickly, and we are empowering developers to stay ahead of the game.”

What’s new in Q2 2024:

UI Components for Generative AI Integration

The new AI Prompt component, available across all Telerik and Kendo UI libraries, enables the creation of quality content, messages and documents, as well as fast access to information through in-UI searches. To reduce the learning curve, AI integration demos in Telerik and Kendo UI libraries for components such as TextBox and Spreadsheet help developers discover new ways to include AI-powered interactions within their digital experiences.

Accelerated Design-to-Production Workflows

While design systems are a must for design consistency, the translation of design to code often causes issues and delays in production time. With today’s release, Progress improves the designer-to-developer handoff with enhanced Figma UI Kits, improved color system themes and enriched design system documentation. Developers can further enable brand consistency and meet app standardization requirements through the newly introduced, unified rendering across the different JavaScript and .NET web frameworks and can leverage more than 600 component-specific theme variables, as well as a smart CSS code editor in Progress® ThemeBuilder℠ cloud application.

Next-Level Accessibility and Inclusivity

commissioned by Progress shows that 76% of developers consider building human-centric applications – with accessibility at the core – more important than it was two years ago. To help them advance their efforts and address users’ specific needs, the Telerik and Kendo UI libraries are compliant with Section 508, WCAG 2.2 and WAI Aria. In addition, all web chart components provide built-in accessibility and keyboard navigation to make data visualizations accessible to all.

Progress also released new capabilities for embedded data-driven experiences with reporting and visualization features, modernization of legacy projects with support for complex migration scenarios and support for .NET 9 Preview.

To learn more about the latest Telerik and Kendo UI releases, visit the  or register for the release webinars: ,  and

About Progress

Progress (Nasdaq: PRGS) provides software that enables organizations to develop and deploy their mission-critical applications and experiences, as well as effectively manage their data platforms, cloud and IT infrastructure. As an experienced, trusted provider, we make the lives of technology professionals easier. Over 4 million developers and technologists at hundreds of thousands of enterprises depend on Progress. Learn more at .

Progress, Telerik, ThemeBuilder, and Kendo UI are trademarks or registered trademarks of Progress Software Corporation and/or one of its subsidiaries or affiliates in the U.S. and other countries. Any other trademarks contained herein are the property of their respective owners.

Press Contacts:

Kim Baker

Progress

7



EN
29/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progress Software Corporation

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 24, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Progress Software Announces Amended Credit Facility

Progress Software Announces Amended Credit Facility New $1.5B facility will support continued growth and provide greater scale and flexibility BURLINGTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) --   (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced that it has entered into a Fifth Amended and Restated Credit Agreement (the “Amended Credit Agreement”), which, among other things, increased the company’s revolving credit facility from $900 million to $1.5 billion and extended the maturity date to July 31, 2030. The Amended Cred...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRGS PROGRESS SOFTWARE CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
PTGX PROTAGONIST THERAPEUTICS
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
BUR BURFORD CAPITAL
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
Anish Jog ... (+4)
  • Anish Jog
  • Daniel Ives
  • Sam Brandeis
  • Steven Wahrhaftig
 PRESS RELEASE

Progress Software Announces Second Quarter 2025 Financial Results

Progress Software Announces Second Quarter 2025 Financial Results Annualized Recurring Revenue ("ARR") of $838 million Grew 46% year-over-yearRevenue of $237 million Grew 36% year-over-yearRaises Full Year Guidance for Revenue, Operating Margin, Earnings Per Share, and Cash FlowAcquires Agentic RAG AI Company BURLINGTON, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced financial results for its fiscal second quarter ended May 31, 2025. Second Quarter 2025 Highligh...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch